INTRODUCTION {#sec1-1}
============

Superficial siderosis (SS) of the central nervous system (CNS) is a rare condition caused by chronic bleeding in the subarachnoid compartment. The source of bleeding remains unknown in up to 35% of cases.\[[@ref31]\]

The pathologic changes associated with SS have been previously described. Macroscopically, the leptomeninges and superficial CNS parenchyma, as well as the subependymal lining throughout the neuroaxis, present a dark, brownish discoloration. Microscopically, extensive hemosiderin deposition can be found in the leptomeninges, as well as in the subpial and subependymal regions. In addition, the leptomeninges are thickened, and varying degrees of neuronal loss, reactive gliosis, and demyelination can be found. In the cerebellum, the superficial folia are almost always involved with loss of Purkinje cells and Bergmann gliosis. Particularly dense hemosiderin deposition can be found in cranial nerve VIII, and to a lesser extent in cranial nerves I and II; these findings are often associated with demyelination and atrophy.\[[@ref38]\]

We present a case of SS caused by an ependymoma with unique radiological and pathological features, and include a revision of the current scientific literature concerning this association.

CASE REPORT {#sec1-2}
===========

History {#sec2-1}
-------

A 35-year-old male was brought to the emergency department after suffering repeated episodes of drop attacks. He was being studied by an ENT specialist because he had complained of drowsiness, gait instability, left neurosensorial hypoacusia, cervicalgia, and multidirectional nystagmus during the last 2 months.

Examination {#sec2-2}
-----------

In the initial neurological examination, he scored 13 in the Glasgow Coma Scale (GCS) (E: 3; V: 4; M: 6), and presented mild papilledema, horizontal-rotatory nystagmus, and instability.

Imaging and initial management {#sec2-3}
------------------------------

Emergent computed tomography (CT) \[[Figure 1a](#F1){ref-type="fig"}\] revealed a heterogeneous fourth ventricle mass causing acute obstructive hydrocephalus (HCP). An emergent insertion of an external ventricular drainage (EVD) was carried out and the patient experienced a complete recovery of his level of consciousness. A brain magnetic resonance imaging (MRI) was then obtained \[Figure [1b](#F1){ref-type="fig"}-[d](#F1){ref-type="fig"}\], which confirmed the presence of a fourth ventricle lesion displaying signs of both intra and extratumoral hemorrhage with SS. These findings suggested a radiological diagnosis of myxopapillary ependymoma versus cavernoma. The panspinal MRI excluded the presence of additional lesions.

![(a) Brain CT showing a 3 × 3× 4 cm 4^th^ ventricle mass, predominantly hyperdense, causing active triventricular dilation. (b) MRI showing a heterogeneous lesion with cystic areas in both T1WI (c) and T2WI (b and d), scarce areas of enhancement (c) and associated edema (b). Linear hypointense signal, in T2WI, along the pial surface/subarachnoid space of the convexity sulci, cerebellar folia, and brainstem and spinal surface, is typical of SS (b, d, e, f). Signs of compensated hydrocephalus are also present (bulging suprasellar cistern, remodellation of the sella turcica) (c and d)](SNI-8-14-g001){#F1}

Operation {#sec2-4}
---------

The tumor was resected through a bilateral telovelar approach with neurophysiological monitoring \[[Figure 2](#F2){ref-type="fig"}\]. The EVD was withdrawn on the second postoperative day.

![Sequence of photographs obtained during the microsurgical procedure. (a and b) A bilateral telovelar approach was carried out. Notice the brownish colored pial surface of the cerebellum, typical of SS. After evacuation of xanthochromic CSF, a rubbery mass was identified occupying the fourth ventricular chamber. A friable xantochromic material covered both the tumor and the boundaries of the fourth ventricle. Although this material facilitated the definition of a plane of dissection that allowed an en block resection of the tumor (c), it precluded the identification of the anatomical structures of the floor of the fourth ventricle (d), except clear CSF gushing forth from the aqueduct](SNI-8-14-g002){#F2}

Pathological findings {#sec2-5}
---------------------

Histologically, the lesion presented a capsule and was mainly composed of great cavernous vessels, with areas of hemorrhages and hemosiderin deposits, thus resembling a cavernous malformation. A scarce tumoral component was found in the periphery of the lesion, which was frequently arranged around hyalinized vessels. Tumoral cells showed an eosinophilic, unclearly delimited cytoplasm and pleomorphic nuclei, with finely granular chromatin and small nucleoli. These tumor cells were glial fibrillary acidic protein (GFAP) positive, and they showed dot-like intracytoplasmic epithelial membrane antigen (EMA) immunoreactivity \[[Figure 3](#F3){ref-type="fig"}\].

![(a) Macroscopic aspect of the lesion, with a heterogeneous surface delimited by a capsule of variable width, which is irregular on one of its borders, with a brownish content. (b) Great vessels with thickened walls of cavernous appearance and minimal areas of tumor in the periphery of the lesion (arrow) (H and E ×4). (c) Tumor cells arranged around hyalinized vessels and signs of recent hemorrhage (H and E ×10). (d) Hemosiderinic pigment (arrows) and tumoral cells with an eosinophilic unclearly delimited cytoplasm and nuclei with finely granular chromatin and small nucleoli (H and E ×40). (e) Perivascular tumor cells express GFAP. (f) Dot-like intracytoplasmic EMA immunoreactivity in tumoral cells](SNI-8-14-g003){#F3}

Postoperative course {#sec2-6}
--------------------

The patient experienced an almost complete recovery from his initial symptoms in the following month, although he still had persistent neurosensorial hypoacusia and nystagmus. Serial follow-up MRI performed 3, 6, and 12 months after surgery showed compensated triventricular dilation and a stable tumoral remnant on the rostral part of the fourth ventricle; however, the patient refused further treatment.

DISCUSSION {#sec1-3}
==========

Approximately 0.9--11% of spontaneous intracranial hematomas are produced by brain neoplasms. Tumors presenting as hemorrhagic lesions have a relatively low frequency (2--11%), and up to 42% remain clinically silent at the time of bleeding.\[[@ref33][@ref62]\] Among tumoral hemorrhages, three patterns can be distinguished, namely, pure intratumoral (53%), pure extratumoral (intraventricular and/or subarachnoid, 33%) and mixed intra and extratumoral hemorrhage (13%).\[[@ref4]\] Intratumoral hemorrhage occurs mainly in highly vascular or malignant neoplasms. Excluding pituitary adenoma, which has been found to have a statistically significant higher frequency, those commonly associated with spontaneous intracranial hemorrhage comprise glial tumors, metastatic tumors, meningioma, and choroid plexus papilloma, the majority of which are described in a supratentorial location. An intracranial hemorrhage originated in a tumor located in the posterior fossa represents a relatively uncommon phenomenon (≤0.4%) with a preference for pediatric patients; the predominant histologies described in this location are pilocytic astrocytoma, medulloblastoma, ependymoma, and melanoma.\[[@ref27][@ref46][@ref62]\]

Those tumors which produce repeated extratumoral hemorrhages may lead to SS. This entity, first described by Hamil in 1908,\[[@ref16]\] was mostly a postmortem diagnosis until the advent of modern neuroradiological techniques. The first description of its radiological features was performed by Gomori in 1985.\[[@ref13]\] Currently, it can be defined as a relatively rare condition in which deposits of hemosiderin accumulate in the subpial layer of the CNS as a consequence of prolonged or recurrent low-grade bleeding into the cerebrospinal fluid, which may lead progressively to irreversible neurological dysfunction. The classic clinical triad consists of sensorineural hearing loss (uni or bilateral), cerebellar ataxia, and myelopathy. The latter, together with cognitive decline, has a propensity to appear in secondary forms of the disease that have progressed over many years. Other symptoms suggestive of arachnoiditis, including neckache, backache, and sciatica, are less frequent. These symptoms are not expected to improve with the treatment of the source of bleeding, as occurred in our patient, and only a slight amelioration has been obtained with the employment of iron chelating agents and radical scavengers.\[[@ref11][@ref28]\]

SS is a secondary condition in up to 65% of cases.\[[@ref31]\] Including the present case, we have recorded a total of 45 published reports of SS in patients with confirmed, nonoperated, current neoplasms of the CNS \[[Table 1](#T1){ref-type="table"}\]. Among these cases, 50% were caused by an ependymal tumor and only 5 were located in the fourth ventricle.\[[@ref6][@ref10][@ref15][@ref50]\] In our case, histopathologically, the mass presented a capsule and was mainly composed of great cavernous vessels, with areas of hemorrhages and hemosiderin deposits -- a sign of recent and old intratumoral bleeding, respectively -- thus microscopically mimicking a cavernoma. The abundant presence of these anomalous vessels was the probable cause of the chronic bleeding, and given its location with free access to the CSF, finally led to the development of SS. A scarce tumoral component was found in the capsule and surrounding these vessels, but lacked areas of fibrillary stroma or perivascular pseudorosettes, which complicated the diagnosis of ependymoma.\[[@ref40]\] Supporting this diagnosis were the GFAP expression and the dot-like intracytoplasmic EMA immunoreactivity found in the tumoral cells. The radiological findings suggested a preoperative differential diagnosis which included cavernous malformation and myxopapillary ependymoma. After revising the literature on the association of these pathologies with SS, we have found 13 cases of cavernoma with secondary SS, none of which had a fourth ventricle location,\[[@ref17][@ref18][@ref24][@ref25][@ref29][@ref30][@ref32][@ref35][@ref42][@ref47][@ref49]\] and all 8 cases secondary to myxopapillary ependymoma had an intraspinal location;\[[@ref12][@ref13][@ref14][@ref20][@ref30][@ref38][@ref45][@ref52]\] thus, it would seem that our differential diagnosis was statistically improbable. All four previously published cases of a fourth ventricular hemorrhagic mass and SS have been diagnosed as ependymoma. We suggest that, in the rare cases where this association is found, the diagnosis of ependymoma should be strongly considered. Nevertheless, the establishment of a definite radiological diagnosis represents a difficult task in such a radiological context as intraventricular cavernomas frequently lack the characteristic peripheral hypointense rim in T2-weighted MRI due to the absence of bleeding into the surrounding brain tissue.\[[@ref5]\]

###### 

Published reports of current, nonoperated CNS tumors presenting with superficial siderosis

![](SNI-8-14-g004)

Chronic HCP has been reported in one-third of those cases presenting SS secondary to current tumors, and has been attributed to impairment of the absorption of CSF caused by subarachnoid adhesions.\[[@ref39][@ref57]\] Although the location of the tumor in our patient may explain by itself the development of HCP, a revision of the other 4 cases of fourth ventricle tumors with SS reveal that, in two there was no HCP,\[[@ref10][@ref50]\] while it was described as mild in the remaining two;\[[@ref6][@ref15]\] therefore, we think that a mixed etiology cannot be completely ruled out in the present case. The drop attacks experienced by our patient were probably caused by transient intratumoral bleeding, producing sudden decompensation of a preexisting HCP. The clinical tolerance of our patient to EVD removal and the presence of triventricular dilation in follow-up MRIs provide additional support for this hypothesis.

CONCLUSION {#sec1-4}
==========

Primary or secondary SS is a rare, progressive condition that can potentially lead to severe and irreversible CNS sequelae. In the case of SS secondary to CNS tumors, the fact that its symptoms at presentation can derive from the tumor itself, SS or both, forces clinicians to be aware of the existence of this entity, since its initial manifestations may be subtle.

Current imaging technology, specifically gradient echo susceptibility T2-weighted MRI, has considerably improved our capacity to establish the diagnosis of SS. The necessity to look for a primary etiology of SS cannot be overemphasized; thus, we think it is mandatory to perform a complete examination of the CNS, once its presence has been determined, to rule out a hemorrhagic lesion. Although the optimal management remains to be determined, if a bleeding source can be established, its surgical ablation appears to halt the progression of the disease, greatly improving the prognosis of the patient.

The present article represents the fifth published case of a fourth ventricle lesion with SS. All have been found to be caused by an ependymoma. We believe that in the future cases associating a fourth ventricle lesion with secondary SS, the diagnosis of ependymoma should be strongly considered.
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Secondary superficial siderosis (SS) is a rare condition in which there is iron staining of the cortical surface or ventricles depending on the location of the causative lesion. SS is not mentioned in the encyclopedic Youmans Neurological Surgery.\[[@ref1a]\] Most neurosurgeons would never have encountered a patient with SS. Neurosurgeons and neuroradiologists should be aware of it because of its potential for causing serious neurological decline.

As the authors state, SS is caused by low-grade chronic or repeated hemorrhage in the subarachnoid space. According to the authors, in 35% of the cases, the source for the hemorrhage is not identified. SS is identified on magnetic resonance imaging (MRI), as described in the article; during surgery, it appears as a brownish discoloration of the brain surface.

SS may cause a multitude of potentially serious and progressive neurological sequelae, which are well described in the article. Espinosa *et al*. have performed a thorough literature search and identified 45 cases of brain tumors associated with SS. Half of the tumors were ependymomas, and 5 of the 45 were in the fourth ventricle. Espinosa *et al*. describe an additional patient with SS caused by an ependymoma in the fourth ventricle.

The authors also point out that the ependymoma of the fourth ventricle could have similar radiological features to a cavernous hemangioma (CH) because in this location there is no typical hemosiderin ring around the CH.

The key point in management is that, when SS is identified on MRI, a thorough search for the source of hemorrhage should be undertaken and the primary pathology should be eliminated. Notwithstanding the necessity to treat the primary lesion, potentially serious neurological decline may thus be avoided.
